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ABSTRACT 
Onchocerciasis among 278 children (0-15yrs) of Ekpan village, a hyperendemic community in Uhunmwode 
Local Government Area of Edo State, Nigeria was investigated using the prevalence of nodules as index. The 
overall prevalence of palpable nodules was 26.3%. Nodule prevalence increased with age and the association was 
found to be statistically significant (P<0.001). More males than females presented with onchocercal nodules; and 
the difference was also found to be statistically significant (P<0.05). Majority of the nodules found were located 
on the head, followed by the abdomen. Of the 186 children eligible to take ivermectin, only 124 (66.7%) actually 
took the drug. The efficacy of ivermectin against onchocerciasis is demonstrated in the observation that those 
who took the drug presented with fewer nodules. Therefore, a timely introduction of eligible children (>5yrs) to 
the treatment programme is advocated.  
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INTRODUCTION 
Ochocerciasis is a serious health and socio-
economic problem in Nigeria and other West 
African countries (1-3). It affects mostly the rural 
population, among who are the farmers who 
produce the bulk of food and industrial raw 
materials. Nigeria is estimated to have 30-40% of 
the world’s cases or 60% of the cases in West 
Africa (4). Studies by Gemade et al. (3) showed 
that the disease was more widely distributed in 
Nigeria than previously assumed. The study 
provided accurate estimates of the population 
living in high risk areas of the disease. In the 
process, the team also identified communities to be 
given priority in the treatment with ivermectin.
 Mass treatment with ivermectin in 
endemic communities usually excludes among 
others children below 5 years of age, although this 
group may constitute a sizeable proportion of some 
communities. According to Akogun (5), children 
under 10 years of age with head nodules have 
serious and irreversible eye lesions which 
significantly affect their visual acuity. Moreover, 
such an untreated population of children along with 
adults refusing to participate in community 
treatment programme with ivermectin, could 
constitute a steady reservoir for the re-infection of 
the treated population. In view of the little attention 
that has been given to this segment of the 
population, we undertook an investigation of 
onchocerciasis in the children of a hyper-endemic 
community in Edo State of Nigeria, using the 
presence of palpable nodules as our index.  
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SUBJECTS AND METHODS  
Study Area  
The study was carried out in Ekpan village, located 
in Uhunmwode Local Government Area of Edo 
State, Nigeria. The village is located in the 
rainforest zone of Nigeria between longitude 
5°56.660′E and latitude 6°43.210′N at an elevation 
of 279m ASL as determined using the Garmin III 
Plus Global Positioning System (GPS). The 
inhabitants of the community are predominantly 
farmers with a population of 643 at the time of this 
study.   
Advocacy and mobilization  
Advocacy visits were paid to the community head, 
seeking consent for the survey. Consent to 
undertake the survey was granted after the 
objectives of the study were highlighted. 
Mobilization of the community for the survey was 
undertaken by the Community Directed Distributor 
of ivermectin (CDD) on the directives of the 
village head and elders committee.  
 
Sampling method  
There were 643 individuals in Ekpan village, 
which constituted the entire population. The mean 
number of the residents per house was 6 while the 
mean number of children (0-15yrs) per house was 
3. A sample size of 264 was derived from a 
microfilaria prevalence of 77% (6) with an added 
10% to improve the response rate to 90%, giving a 
final sample size of 293. All children 0-15yrs born 
in the community were eligible to participate in the 
study. However, only 278/293 consented to 
participate in the survey, giving a 94.8% response 
rate. The participants were examined from their 
head to the feet for the presence of palpable 
nodules. Number of observed nodules and site of 
occurrence were noted and recorded. Examination 
for palpable nodules was undertaken in individual 
participant’s houses under minimal privacy.  
 
Data collection and analysis  
Data collected were analyzed using PEPI (7), the 
computer programme for epidemiological studies 




Prevalence of nodules by age and sex  
A total of 278 children comprising 133 (47.8%) 
males and 145 (52.2%) females were studied in 
Ekpan village (Table 1). The ages of the children 
ranged from 0-15 years with a majority, 150 
(54.0%) in the 5-10 years age group, followed by 
those in the 0-4 years age with 92 (33.1%). The 
overall prevalence of palpable onchocercal nodules 
was 26.3%. The prevalence of palpable nodules 
among the affected children increased with age as 
also shown in Table 1 and the association was 
found to be statistically significant (P<0.001). 
More males than females presented with palpable 
onchocercal nodules; and the difference was also 
found to be statistically significant (P<0.05).  
 
Distribution of nodules on the affected children 
Figure 1 shows the distribution of palpable nodules 
in different parts of the body of the affected 
children. Majority 60 (21.6%) of the nodules were 
located on the head, followed by the abdomen with 
44 (15.8%) and the thorax with 38 (13.7%). 
 
Ivermectin intake and nodule prevalence  
Table 2 shows that 92 (33.1%) of the children 
studied were underfives and these were not eligible 
to take ivermectin. The children eligible for 
ivermectin were the 186 (66.9%) who were 5 years 
and above and of this number only 124 (66.7%) of 
them actually took the drug. Table 3 shows the 
prevalence of palpable nodules among children 
who were eligible for ivermectin. Prevalence of 
palpable onchocercal nodules was higher among 
the untreated than in the treated and the difference 





























Fig. 1. Distribution of palpable nodules on the  












Table 1. Overall prevalence of palpable nodules  
among the children of Ekpan village by age and 
sex.  
































































Table 2. Age, ivermectin intake and frequency 
of  
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Table 3. Prevalence of palpable nodules among  
children eligible to receive ivermectin treatment 
 
 








































The use of palpable onchocercal nodule 
prevalence as index for determining the level of 
endemicity in communities has been in practice 
since its validation in Nigeria (8, 9) except that it 
was used for adults and the threshold for 
treatment in endemic communities set at 20% 
(10). Following its validation in Nigeria, nodule 
palpation became the method of choice for rapid 
community diagnosis of onchocerciasis and its 
validity has since been confirmed by several 
independent studies (11-13). For our study, the 
attractiveness of this method lay in its non-
invasiveness as against skin-snipping which is 
resented among the adult population and dreaded 
by children. Other reasons for which nodule 
palpation has been recommended include its 
simplicity, applicability and practicability, 
acceptability and non-technicality 
(3,11,13,14,15). Furthermore, this method has 
been found to reduce blood transmissible 
infections such as HIV/AIDS and hepatitis B 
(16,17).  
 
The overall prevalence of nodules among the 
children studied was 26.3% compared with the 
38.7%in the adult population from the same 
study location (18). This result pattern, which 
has also been observed elsewhere (19) shows 
that infection is acquired early in life in this 
community.  
 
The prevalence of nodules was observed to 
increase with age. This observation conforms to 
the pattern of the disease (5,19-26). 
Consequently, in hyper-endemic communities 
such as Ekpan, where transmission is already 
intense at young age, the process of early 
infection may predispose most individuals to 
acquiring increasingly higher worm burden as 
age progresses (12). Differences observed in the 
prevalence of nodules between male and female 
children tend to suggest that male children are 
more exposed to infective bites. In farming 
communities such as Ekpan it is common 
practice for young males to accompany their 
fathers to work in the farm thus exposing them 
more to Simulium bites. This observation is in 
good agreement with those of Brabin (27) who 
concluded that any gender-specific differences in 
symptomatology and microfilarial densities 
derive from differences in exposure rather than 
from inherent sex differences. 
 
On the distribution of nodules, it was observed to 
be more on the head and trunk of the children 
studied. In Africa where S. damnosum and S. 
neavvei complexes bite mainly on the ankles and 
legs of adults, nodules are most commonly 
located around the pelvics. In children however, 
because their head is closer to the ground than 
those of the adults, it makes the head and trunk 
the likely sites open to infective bites (28). 
Moreover, the head of infants may be the only 
area exposed when on their mother’s back or 
when laid on the ground while their mothers are 
busy with farming (28).  
 
With the low prevalence of nodules among the 
underfives (Table 2), it is obvious that this group 
does not constitute a significant source of 
infection in the community. This is in good 
agreement with the observations of Duke and 
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Moore (20) who in their study of different age 
groups in a Cameroon forest village concluded 
that apart from occasional individuals, children 
under 5 yrs are of little importance as a source of 
transmission. This cannot be said of children, 
5yrs and above, who are infected and very 
accessible to Simulium flies when they engage in 
farming and other outdoor activities in the 
community. If this segment of the population is 
neglected in the ongoing ivermectin treatment 
programme in the community, they may 
constitute a good reservoir of infection and re-
infection for the treated population. It needs to be 
stressed that adults in the community need to 
take the annual treatment programme more 
seriously as this will effectively reduce the 
microfilariae available for transmission to the 
younger members of the community.  
 
From the results presented in Table 3, it is 
obvious that ivermectin is efficacious in the 
control of onchocerciasis as children who took 
the drug presented with fewer nodules. Apart 
from the microfilaricidal effect of ivermectin, the 
drug has been shown to reduce fecundity and 
cause death of as much as 30% of adult 
Onchocerca volvulus (29, 30). From the 
foregoing, it is obvious that timely introduction 
of eligible children (5yrs and above) in endemic 
communities to ivermectin treatment will reduce 
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